Literature DB >> 25286950

Crystallization and preliminary X-ray diffraction analyses of the redox-controlled complex of terminal oxygenase and ferredoxin components in the Rieske nonhaem iron oxygenase carbazole 1,9a-dioxygenase.

Jun Matsuzawa1, Hiroki Aikawa1, Takashi Umeda1, Yuji Ashikawa1, Chiho Suzuki-Minakuchi1, Yoshiaki Kawano2, Zui Fujimoto3, Kazunori Okada1, Hisakazu Yamane4, Hideaki Nojiri1.   

Abstract

The initial reaction in bacterial carbazole degradation is catalyzed by carbazole 1,9a-dioxygenase, which consists of terminal oxygenase (Oxy), ferredoxin (Fd) and ferredoxin reductase components. The electron-transfer complex between reduced Oxy and oxidized Fd was crystallized at 293 K using the hanging-drop vapour-diffusion method with PEG 3350 as the precipitant under anaerobic conditions. The crystal diffracted to a maximum resolution of 2.25 Å and belonged to space group P21, with unit-cell parameters a = 97.3, b = 81.6, c = 116.2 Å, α = γ = 90, β = 100.1°. The VM value is 2.85 Å(3) Da(-1), indicating a solvent content of 56.8%.

Entities:  

Keywords:  Rieske nonhaem iron oxygenase; carbazole 1,9a-dioxygenase; electron-transfer complex; ferredoxin; terminal oxygenase

Mesh:

Substances:

Year:  2014        PMID: 25286950      PMCID: PMC4188090          DOI: 10.1107/S2053230X14018779

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


Introduction

Rieske nonhaem iron oxygenases (ROs) play an important role as the initial enzymes in aromatic compound catabolic pathways (Gibson & Parales, 2000 ▶; Parales & Resnick, 2006 ▶). ROs consist of two or three discrete soluble components. Two-component ROs consist of reductase (Red) and terminal oxygenase (Oxy) components, whereas three-component ROs consist of Red, ferredoxin (Fd) and Oxy components. Oxy invariably contains a Rieske-type [2Fe–2S] cluster and a nonhaem iron active centre involved in dioxygen activation and it catalyzes the incorporation of molecular dioxygen into the substrate. Although there are variations in the redox-transfer machineries in both Fd and Red, these electron-transfer components transfer electrons from NAD(P)H to Oxy. Carbazole 1,9a-dioxygenase (CARDO) was originally isolated from Pseudomonas resinovorans CA10 as the initial enzyme of the carbazole-degradation pathway, and similar degradation systems have subsequently been reported in several other bacteria, for example Nocardioides aromaticivorans IC177, Novosphingobium sp. KA1 and Janthinobacterium sp. J3 (Nojiri & Omori, 2006 ▶; Nojiri, 2012 ▶; Inoue & Nojiri, 2014 ▶). The amino-acid sequences of CARDO components from CA10 are nearly identical to those of J3, and the components can replace each other. Therefore, using the CARDO components from CA10 and J3, we have evaluated the reaction cycle and the electron-transfer mechanism among components in RO, especially between Fd and Oxy, by determining the crystal structures of the oxidized forms of Fd from CA10 (Nam et al., 2005 ▶) and Oxy from J3 (Nojiri et al., 2005 ▶) and of the complex forms of Oxy from J3 and Fd from CA10 (Ashikawa et al., 2006 ▶). Recently, substrate-bound and oxygen-bound forms of the Oxy–Fd complex were determined and the catalytic cycle of Oxy was elucidated from a structural viewpoint (Ashikawa et al., 2012 ▶). Crystals of Oxy alone, Fd alone and Oxy–Fd complexes and the conditions for their formation are summarized in Table 1 ▶.
Table 1

Crystallization conditions of Oxy, Fd and OxyFd

NA, not applicable. CAR = carbazole.

   Treatment of the crystal formed 
 ConditionSpace groupReductionCAR exposureAir exposureReference
Oxyox Aerobic, hanging drop, 293K, 1719%(v/v) MPD, 0.1M MES pH 6.2 P213NANANANojiri et al. (2005)
Oxyred Anaerobic, hanging drop, 293K, 30%(v/v) PEG MME 550, 0.05M MgCl2 6H2O, 0.1M HEPES pH 7.5 P65 NANANAMatsuzawa et al. (2013)
Fdox Aerobic, hanging drop, 278K, 1719%(w/v) PEG MME 2000, 0.2M (NH4)2SO4, 0.02M MgCl2 6H2O, 0.1M sodium acetate pH 4.6 P4132NANANANam et al. (2005)
OxyoxFdox Aerobic, hanging drop, 293K, 12mM sodium dithionite, 14%(w/v) PEG MME 2000, 0.05M Bis-Tris pH 6.5 P21 NANANAAshikawa et al. (2006)
OxyredFdred YesNANA
OxyoxFdoxCARNAYesNA
OxyredFdredCARYesYesNAAshikawa et al. (2012)
OxyoxFdoxO2 YesNAYes
OxyoxFdoxO2CARYesYesYes
OxyredFdox Anaerobic, hanging drop, 293K, 14%(w/v) PEG 3350, 0.1M sodium cacodylate pH 5.7 P21 NANANAThis study
Electron transfer between Oxy and Fd components is proposed to proceed in three steps (Fig. 1 ▶). Firstly, Fdred associates with Oxyox (where the subscripts ‘ox’ and ‘red’ indicate the oxidized and reduced states, respectively). Next, the electron is transferred from Fdred to Oxyox and the redox states of the components are reverted. Finally, Fdox dissociates from Oxyred. To accomplish these sequential steps effectively, the manner of interaction between Oxy and Fd should be altered according to the redox states of the respective components. This is supported by the observation that redox-state-dependent structural change triggers the association/dissociation of the Red and Fd components of biphenyl 2,3-dioxygenase (Senda et al., 2007 ▶). However, our previously solved complex structures of Oxy and Fd, of both oxidized OxyoxFdox and reduced Oxyred–Fdred (Ashikawa et al., 2006 ▶), do not appear in the catalytic cycle of the CARDO reaction; however, the structures clearly revealed the binding region between the two components. Clarification of the manner of interaction between Oxyred and Fdox or between Oxyox and Fdred would facilitate an understanding of the redox-dependent association/dissociation mechanism between Oxy and Fd components in RO based on comparisons among the structures in the actual catalytic cycle. Here, we report crystallization and preliminary X-ray diffraction studies of the complex crystal structures of Oxyred and Fdox in CARDO.
Figure 1

The electron-transfer reaction between the Oxy and Fd components of CARDO. Reduced and oxidized states of the components are shown in blue and red, respectively. Electrons are shown as pink spheres labelled e−. The black arrow in the proposed complex state (Oxyox–Fdred) in parentheses shows electron transfer from the Rieske-type [2Fe–2S] cluster of Fdred to the Rieske-type [2Fe–2S] cluster of Oxyox. The Oxyred–Fdox complex obtained in this study is shown against a grey background.

Methods and results

Purification, anaerobic procedure and protein reduction

The Oxy component of CARDO from Janthinobacterium sp. J3 and the Fd component of CARDO from P. resinovorans CA10 were purified as described previously (Ashikawa et al., 2005 ▶; Matsuzawa et al., 2013 ▶). Briefly, histidine-tagged Oxy and Fd were expressed in Escherichia coli BL21(DE3) (Novagen, Madison, Wisconsin, USA) and purified using metal-chelation chromatography followed by gel-filtration chromatography. After purification, Oxy and Fd were subjected to ultrafiltration and buffer-exchanged into 50 mM TrisHCl pH 7.5 using Vivaspin 20 membranes (10 000 MWCO; Sartorius, Göttingen, Germany) and Centriprep YM-10 (Millipore, Bedford, Massachusetts, USA), respectively. These protein solutions were flash-frozen in liquid nitrogen and stored at 193 K. To prepare the Oxy and Fd solutions for the anaerobic crystallization experiments, an anaerobic chamber filled with 95% N2 and 5% H2 was used as described previously (Matsuzawa et al., 2013 ▶). Purified Oxy and Fd were put into the anaerobic chamber and incubated for several hours on ice to remove the dissolved oxygen. Oxy was then reduced using two equivalents of sodium dithionite dissolved in deoxygenated 50 mM TrisHCl pH 7.5. Fd and reduced Oxy were separately concentrated and buffer-exchanged four times into deoxygenated 50 mM Tris using Nanosep 10K Omega devices (Pall, Port Washington, New York, USA) to eliminate the dissolved oxygen and remaining sodium dithionite (in the case of Oxy). Aliquots of the protein solutions were subsequently added to individual quartz cells sealed with butyl rubber caps and the redox states were confirmed by measuring the absorption spectra as described previously (Matsuzawa et al., 2013 ▶). Oxy and Fd showed the peaks characteristic of the redox states of the Rieske [2Fe–2S] cluster: Oxyred, 420 and 525 nm; Oxyox, 459 and 560 nm; Fdred, 432 and 515 nm; and Fdox, 457 and 570 nm (Nam et al., 2002 ▶). Protein concentrations were estimated using a protein assay kit (Bio-Rad, Richmond, California, USA) with BSA as the standard.

Crystallization

For crystallization experiments, Oxyred and Fdox were mixed in a 1:3 molar ratio and then mixed with glycerol as an additive. Total protein concentration was adjusted to 15–30 mg ml−1 and the glycerol concentration was adjusted to 10%(v/v). Crystallization was performed using the hanging-drop vapour-diffusion method at 293 K. Drops consisting of 2 µl protein solution and 2 µl mother liquor were equilibrated against 400–600 µl reservoir solution. The initial crystallization conditions were screened using Crystal Screen, Crystal Screen 2, Crystal Screen Cryo and Index (Hampton Research, Laguna Hills, California, USA) and the Crystallization Kit for Protein Complexes (Sigma–Aldrich, St Louis, Missouri, USA). Several crystals were obtained using the Crystallization Kit for Protein Complexes condition No. 12 [0.1 M sodium cacodylate pH 6.5, 20% (w/v) PEG 3350]. To improve the crystallization conditions, the pH and precipitant concentration were assessed. Finally, plate-shaped crystals were obtained using 0.1 M sodium cacodylate pH 5.7, 14%(w/v) PEG 3350 (Table 1 ▶, Fig. 2 ▶). Crystal growth was observed after 1–2 d. SDS–PAGE and Western blot analysis were performed to verify the presence of both Oxy and Fd in these crystals. The crystals obtained in this study were dissolved in 5 mM TrisHCl. The resulting protein, Oxy and Fd solutions were subjected to SDS–PAGE and stained with Coomassie Brilliant Blue. Although there were two bands corresponding to the sizes of Oxy and Fd, possible degradation peptides derived from Oxy were also detected (Fig. 3 ▶ a, lanes 1 and 3). After SDS–PAGE, the proteins were also transferred onto Sequi-Blot polyvinylidene difluoride (PVDF) membranes (Bio-Rad). Oxy and Fd were detected using anti-His antibody (GE Healthcare, Buckinghamshire, England) as the primary antibody and HRP-linked anti-mouse antibody (GE Healthcare) as the secondary antibody. Signals were visualized using the Luminescent Image Analyzer LAS-1000 Plus (Fujifilm, Tokyo, Japan). The hybridization signals for possible Oxy degradation peptides were not detected, while signals corresponding to the positions of Fd and Oxy were clearly detected in the obtained crystal (Fig. 3 ▶ b), indicating an Oxy–Fd binary complex.
Figure 2

Crystals of the binary complex between the reduced state of Oxy from Janthinobacterium sp. J3 and the oxidized state of Fd from P. resinovorans CA10. Plate-shaped crystals in the drop (a) and one piece of the crystal (b) are shown. The scale bar is 0.3 mm in length.

Figure 3

SDS–PAGE followed by Western blot analysis of Oxy and Fd complex crystals. (a) The dissolved crystals were verified by SDS–PAGE. Lane M, Precision Plus Protein Dual Color Standards (Bio-Rad; labelled in kDa); lane 1, Oxy solution used for crystallization; lane 2, Fd solution used for crystallization; lane 3, dissolved crystals of the complex. Approximately 3 µg protein was loaded per lane. (b) A Western blot stained with the anti-His antibody is shown; the lane numbers are the same as those in (a).

Determination of the redox states of the crystals

To verify the redox state of each component in the crystals, the absorption spectrum of crystals of the binary complex was measured using a microspectrophotometer under a cryostream of nitrogen at 100 K (Chiu et al., 2006 ▶). The microspectrophotometer system consisted of a deuterium tungsten halogen light (DT-MINI; Ocean Optics, Tokyo, Japan), Cassegrainian mirrors (Bunkoh-Keiki, Tokyo, Japan), an optical fibre and a linear CCD array spectrometer (SD2000; Ocean Optics). The crystals showed characteristic peaks at around 460 nm and peak shoulders at 525–540 and 570–590 nm (Fig. 4 ▶). In comparison with previous results (Nam et al., 2002 ▶; Matsuzawa et al., 2013 ▶), the peak at around 460 nm and the peak shoulder at 570–590 nm suggested that the Rieske [2Fe–2S] cluster in Fd was oxidized, because the oxidized form of Oxy shows a peak shoulder at a shorter wavelength such as 550–570 nm. On the other hand, the peak shoulder at 530–540 nm suggested that the Rieske [2Fe–2S] cluster of Oxy was reduced, because the reduced form of Fd shows a peak shoulder at a shorter wavelength such as 510–520 nm (Nam et al., 2002 ▶; Matsuzawa et al., 2013 ▶). Accordingly, the crystals were found to be composed of Oxyred and Fdox.
Figure 4

Absorption spectrum of binary-complex crystals. The blue arrow indicates the peak shoulder specific for reduced Oxy (530–540 nm) and the red arrows indicate those specific for oxidized Fd (460 and 570–590 nm).

Data collection

The crystals were cryocooled using liquid nitrogen in an anaerobic chamber with a mixture of 0.1 M sodium cacodylate pH 5.7, 14% PEG 3350 and 15% glycerol as a cryoprotectant. X-ray diffraction data were collected on a MAR225 CCD detector at 100 K using synchrotron radiation of wavelength 1.0 Å on BL26B2 at SPring-8 (Harima, Japan) and were processed using HKL-2000 (Otwinowski & Minor, 1997 ▶). The crystals diffracted to 2.25 Å resolution and belonged to space group P21, with unit-cell parameters a = 97.3, b = 81.6, c = 116.2 Å, α = γ = 90, β = 100.1°. The data-collection and processing statistics are shown in Table 2 ▶. The structure of the OxyoxFdox binary complex (PDB entry 2de5; Ashikawa et al., 2006 ▶) was used as a molecular-replacement model for MOLREP (Winn et al., 2011 ▶; Vagin & Teplyakov, 2010 ▶). Although previous Oxy–Fd binary-complex crystals consisted of three molecules of the Fd monomer and one molecule of the Oxy trimer, the complex structure calculated from these crystals lacked one molecule of the Fd monomer and contained only two molecules of the Fd monomer per one Oxy trimer. After recalculation of this structure, the Matthews coefficient (V M; Matthews, 1968 ▶) was found to be 2.85 Å3 Da−1, indicating a solvent content of 56.8%.
Table 2

Crystal parameters and data-collection statistics

Values in parentheses are for the highest resolution shell.

Space group P21
Unit-cell parameters (, ) a = 97.3, b = 81.6, c = 116.2, = = 90, = 100.1
BeamlineBL26B2, SPring-8
Wavelength ()1.000
Rotation range per image ()0.5
Total rotation range ()360
Exposure time per image (s)10
Crystal-to-detector distance (mm)213.50
Resolution range ()50.002.25 (2.332.25)
Total No. of reflections579068
No. of unique reflections82730 (7180)
Completeness (%)97.0 (84.7)
Mosaicity ()0.54 0.86
Average I/(I)42.6 (3.5)
R merge (%)6.8 (38.1)
Multiplicity7.0 (5.4)
Overall B factor from Wilson plot (2)46.9

R merge = , where I(hkl) is the ith observation of reflection hkl and I(hkl) is the weighted average intensity for all observations of reflection hkl.

A full description of the structure determination followed by interpretation of the structure–function relationship will be published elsewhere.
  14 in total

1.  Crystallization and preliminary X-ray diffraction analysis of the electron-transfer complex between the terminal oxygenase component and ferredoxin in the Rieske non-haem iron oxygenase system carbazole 1,9a-dioxygenase.

Authors:  Yuji Ashikawa; Zui Fujimoto; Haruko Noguchi; Hiroshi Habe; Toshio Omori; Hisakazu Yamane; Hideaki Nojiri
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-06-01

2.  Crystallization and preliminary X-ray diffraction studies of the reduced form of the terminal oxygenase component of the Rieske nonhaem iron oxygenase system carbazole 1,9a-dioxygenase.

Authors:  Jun Matsuzawa; Takashi Umeda; Hiroki Aikawa; Chiho Suzuki; Zui Fujimoto; Kazunori Okada; Hisakazu Yamane; Hideaki Nojiri
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-10-30

3.  Molecular replacement with MOLREP.

Authors:  Alexei Vagin; Alexei Teplyakov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

4.  Structure of the terminal oxygenase component of angular dioxygenase, carbazole 1,9a-dioxygenase.

Authors:  Hideaki Nojiri; Yuji Ashikawa; Haruko Noguchi; Jeong-Won Nam; Masaaki Urata; Zui Fujimoto; Hiromasa Uchimura; Tohru Terada; Shugo Nakamura; Kentaro Shimizu; Takako Yoshida; Hiroshi Habe; Toshio Omori
Journal:  J Mol Biol       Date:  2005-08-12       Impact factor: 5.469

Review 5.  Structural and molecular genetic analyses of the bacterial carbazole degradation system.

Authors:  Hideaki Nojiri
Journal:  Biosci Biotechnol Biochem       Date:  2012-01-07       Impact factor: 2.043

6.  Electron transfer complex formation between oxygenase and ferredoxin components in Rieske nonheme iron oxygenase system.

Authors:  Yuji Ashikawa; Zui Fujimoto; Haruko Noguchi; Hiroshi Habe; Toshio Omori; Hisakazu Yamane; Hideaki Nojiri
Journal:  Structure       Date:  2006-12       Impact factor: 5.006

7.  Crystal structure of the ferredoxin component of carbazole 1,9a-dioxygenase of Pseudomonas resinovorans strain CA10, a novel Rieske non-heme iron oxygenase system.

Authors:  Jeong-Won Nam; Haruko Noguchi; Zui Fujimoto; Hiroshi Mizuno; Yuji Ashikawa; Mitsuru Abo; Shinya Fushinobu; Nobuyuki Kobashi; Takayoshi Wakagi; Kenichi Iwata; Takako Yoshida; Hiroshi Habe; Hisakazu Yamane; Toshio Omori; Hideaki Nojiri
Journal:  Proteins       Date:  2005-03-01

8.  Molecular mechanism of the redox-dependent interaction between NADH-dependent ferredoxin reductase and Rieske-type [2Fe-2S] ferredoxin.

Authors:  Miki Senda; Shinya Kishigami; Shigenobu Kimura; Masao Fukuda; Tetsuo Ishida; Toshiya Senda
Journal:  J Mol Biol       Date:  2007-08-19       Impact factor: 5.469

9.  Structural insight into the substrate- and dioxygen-binding manner in the catalytic cycle of rieske nonheme iron oxygenase system, carbazole 1,9a-dioxygenase.

Authors:  Yuji Ashikawa; Zui Fujimoto; Yusuke Usami; Kengo Inoue; Haruko Noguchi; Hisakazu Yamane; Hideaki Nojiri
Journal:  BMC Struct Biol       Date:  2012-06-24

10.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.